GSK press releases Follow Hibsago (bepirovirsen) approved in the US for the treatment of chronic hepatitis B (CHB) Approval based on phase III data showing unprecedented functional cure rates compared to standard of care https://www.gsk.com/en-gb/media/press-releases/hibsago-bepirovirsen-approved-in-the-us-for-the-treatment-of-chronic-hepatitis-b-chb/ gsk.com
